Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose (Q30441575)

15 August 2017

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose (English)

1 reference

15 August 2017

1 reference

1 reference

1 reference

16

Thomas A E Platts-Mills

1 reference

15 August 2017

8

Shama M Satinover

1 reference

15 August 2017

Christine H Chung

1

1 reference

15 August 2017

Beloo Mirakhur

2

1 reference

15 August 2017

Emily Chan

3

1 reference

15 August 2017

Quynh-Thu Le

4

1 reference

15 August 2017

Jordan Berlin

5

1 reference

15 August 2017

Michael Morse

6

1 reference

15 August 2017

Barbara A Murphy

7

1 reference

15 August 2017

Jacob Hosen

9

1 reference

15 August 2017

David Mauro

10

1 reference

15 August 2017

Robbert J Slebos

11

1 reference

15 August 2017

Qinwei Zhou

12

1 reference

15 August 2017

Diane Gold

13

1 reference

15 August 2017

Tina Hatley

14

1 reference

15 August 2017

Daniel J Hicklin

15

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

The New England Journal of Medicine

15 August 2017

1 reference

15 August 2017

358

1 reference

15 August 2017

11

1 reference

15 August 2017

1109-1117

1 reference

Prevalence and titer of IgE antibodies to mouse allergens

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequentia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Cat IgA, representative of new carbohydrate cross-reactive allergens

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Functionally important glycosyltransferase gain and loss during catarrhine primate emergence

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

ABO blood group and related antigens, natural antibodies and transplantation.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Definition of immunogenic carbohydrate epitopes.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Quantitative measurement of IgE antibodies to purified allergens using streptavidin linked to a high-capacity solid phase

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Retrospective analysis of the safety of Herceptin immunotherapy in metastatic breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Monoclonal antibodies to the major feline allergen Fel d I. II. Single step affinity purification of Fel d I, N-terminal sequence analysis, and development of a sensitive two-site immunoassay to assess Fel d I exposure.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

High prevalence of IgE antibodies among blood donors in Sweden and Norway

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

The diagnosis and management of anaphylaxis: an updated practice parameter

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Symposium on the definition and management of anaphylaxis: summary report.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

The role of indoor allergen sensitization and exposure in causing morbidity in women with asthma.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

Poor biologic activity of cross-reactive IgE directed to carbohydrate determinants of glycoproteins.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361129

High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history

26 November 2018

1 reference

12 December 2020

The incidence and management of infusion reactions to infliximab: a large center experience

1 reference

12 December 2020

Monoclonal antibodies, immunogenicity, and associated infusion reactions

1 reference

12 December 2020

[Evaluation of the analytical performance of the ImmunoCap 250 (Sweden Diagnostics)]

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA074943

1 reference

15 August 2017

1 reference

15 August 2017

1 reference